Alexander Willemse is the CEO of BioConnection BV since 2008.
Before joining BioConnection, Alexander built an extensive career within the pharmaceutical industry. He started at Organon NV in 1998 and joined OctoPlus in 2003, where he served as Managing Director of the CMO business. Alexander studied Chemical Engineering at Delft University of Technology, where he also earned his PhD. Throughout his career, he has shared his expertise as a lecturer at several universities, including courses such as Particle Size Measurement for Aerosol Systems at the University of California (UCLA) and Measuring Techniques for Biophysical Systems at the University of Leuven in Belgium. For many years, he contributed as a CMC expert to the course Drug Development Simulation, first through the Dutch Top Institute Pharma and later via Learning by Simulation. Alexander is (co-)author of more than 20 scientific publications and currently serves as a board member of HollandBIO, the association of biotech companies in the Netherlands. In recent years, he has also delivered an annual guest lecture at Delft University of Technology on the history and impact of injectable pharmaceutical development. Outside of work, Alexander enjoys spending time with his family. When time allows, he can often be found mountain biking, and during winter he enjoys skiing on slopes around the world.
“It is rewarding to see how our work contributes to the success of our customers and, ultimately, to the availability of new therapies. Over the past few years, the company has grown significantly, and we are committed to continuing this growth. I find the work both diverse and challenging, but above all it is our people who make the difference. We are a strong, dedicated team with a great spirit, always willing to go the extra mile for our projects and customers. Combined with a healthy sense of humor and a practical, down-to-earth approach, this truly makes for a winning team.”